世界のα-アドレナリン受容体拮抗薬市場インサイト及び予測(~2026年)

【英語タイトル】Global Alpha-Adrenoreceptor Antagonists Market Insights and Forecast to 2026

QYResearchが出版した調査資料(QYR20NV02293)・商品コード:QYR20NV02293
・発行会社(調査会社):QYResearch
・発行日:2020年11月(※2024年版があります。お問い合わせください)
・ページ数:145
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:化学・材料
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートはα-アドレナリン受容体拮抗薬の世界市場について調査・分析した資料です。種類別(経口、注射)の市場規模、用途別(病院、クリニック)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別α-アドレナリン受容体拮抗薬の競争状況、市場シェア
・世界のα-アドレナリン受容体拮抗薬市場:種類別市場規模 2015年-2020年(経口、注射)
・世界のα-アドレナリン受容体拮抗薬市場:種類別市場規模予測 2021年-2026年(経口、注射)
・世界のα-アドレナリン受容体拮抗薬市場:用途別市場規模 2015年-2020年(病院、クリニック)
・世界のα-アドレナリン受容体拮抗薬市場:用途別市場規模予測 2021年-2026年(病院、クリニック)
・北米のα-アドレナリン受容体拮抗薬市場分析:米国、カナダ
・ヨーロッパのα-アドレナリン受容体拮抗薬市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのα-アドレナリン受容体拮抗薬市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のα-アドレナリン受容体拮抗薬市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのα-アドレナリン受容体拮抗薬市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Sanofi、Pfizer、Pro Doc、Concordia Pharmaceuticals、Covis Pharmaceuticals、Aspri Pharma、Roerig、Greenstone、Boehringer Ingelheim、Cardinal Health、Teva、Glaxosmithkline、Actavis、Merck、Jubilant Generics、Astellas Pharma、Allergan
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Alpha-Adrenoreceptor Antagonists Market
The global Alpha-Adrenoreceptor Antagonists market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Alpha-Adrenoreceptor Antagonists Scope and Market Size
Alpha-Adrenoreceptor Antagonists market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Alpha-Adrenoreceptor Antagonists market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Alpha-Adrenoreceptor Antagonists market is segmented into
Oral
Injection

Segment by Application, the Alpha-Adrenoreceptor Antagonists market is segmented into
Hospital
Clinic

Regional and Country-level Analysis
The Alpha-Adrenoreceptor Antagonists market is analysed and market size information is provided by regions (countries).
The key regions covered in the Alpha-Adrenoreceptor Antagonists market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Alpha-Adrenoreceptor Antagonists Market Share Analysis
Alpha-Adrenoreceptor Antagonists market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Alpha-Adrenoreceptor Antagonists business, the date to enter into the Alpha-Adrenoreceptor Antagonists market, Alpha-Adrenoreceptor Antagonists product introduction, recent developments, etc.

The major vendors covered:
Sanofi
Pfizer
Pro Doc
Concordia Pharmaceuticals
Covis Pharmaceuticals
Aspri Pharma
Roerig
Greenstone
Boehringer Ingelheim
Cardinal Health
Teva
Glaxosmithkline
Actavis
Merck
Jubilant Generics
Astellas Pharma
Allergan

【レポートの目次】

1 Study Coverage
1.1 Alpha-Adrenoreceptor Antagonists Product Introduction
1.2 Market Segments
1.3 Key Alpha-Adrenoreceptor Antagonists Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Alpha-Adrenoreceptor Antagonists Market Size Growth Rate by Type
1.4.2 Oral
1.4.3 Injection
1.5 Market by Application
1.5.1 Global Alpha-Adrenoreceptor Antagonists Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Alpha-Adrenoreceptor Antagonists Market Size, Estimates and Forecasts
2.1.1 Global Alpha-Adrenoreceptor Antagonists Revenue 2015-2026
2.1.2 Global Alpha-Adrenoreceptor Antagonists Sales 2015-2026
2.2 Global Alpha-Adrenoreceptor Antagonists, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Alpha-Adrenoreceptor Antagonists Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Alpha-Adrenoreceptor Antagonists Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Alpha-Adrenoreceptor Antagonists Competitor Landscape by Players
3.1 Alpha-Adrenoreceptor Antagonists Sales by Manufacturers
3.1.1 Alpha-Adrenoreceptor Antagonists Sales by Manufacturers (2015-2020)
3.1.2 Alpha-Adrenoreceptor Antagonists Sales Market Share by Manufacturers (2015-2020)
3.2 Alpha-Adrenoreceptor Antagonists Revenue by Manufacturers
3.2.1 Alpha-Adrenoreceptor Antagonists Revenue by Manufacturers (2015-2020)
3.2.2 Alpha-Adrenoreceptor Antagonists Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Alpha-Adrenoreceptor Antagonists Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Alpha-Adrenoreceptor Antagonists Revenue in 2019
3.2.5 Global Alpha-Adrenoreceptor Antagonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Alpha-Adrenoreceptor Antagonists Price by Manufacturers
3.4 Alpha-Adrenoreceptor Antagonists Manufacturing Base Distribution, Product Types
3.4.1 Alpha-Adrenoreceptor Antagonists Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Alpha-Adrenoreceptor Antagonists Product Type
3.4.3 Date of International Manufacturers Enter into Alpha-Adrenoreceptor Antagonists Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Alpha-Adrenoreceptor Antagonists Market Size by Type (2015-2020)
4.1.1 Global Alpha-Adrenoreceptor Antagonists Sales by Type (2015-2020)
4.1.2 Global Alpha-Adrenoreceptor Antagonists Revenue by Type (2015-2020)
4.1.3 Alpha-Adrenoreceptor Antagonists Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Alpha-Adrenoreceptor Antagonists Market Size Forecast by Type (2021-2026)
4.2.1 Global Alpha-Adrenoreceptor Antagonists Sales Forecast by Type (2021-2026)
4.2.2 Global Alpha-Adrenoreceptor Antagonists Revenue Forecast by Type (2021-2026)
4.2.3 Alpha-Adrenoreceptor Antagonists Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Alpha-Adrenoreceptor Antagonists Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Alpha-Adrenoreceptor Antagonists Market Size by Application (2015-2020)
5.1.1 Global Alpha-Adrenoreceptor Antagonists Sales by Application (2015-2020)
5.1.2 Global Alpha-Adrenoreceptor Antagonists Revenue by Application (2015-2020)
5.1.3 Alpha-Adrenoreceptor Antagonists Price by Application (2015-2020)
5.2 Alpha-Adrenoreceptor Antagonists Market Size Forecast by Application (2021-2026)
5.2.1 Global Alpha-Adrenoreceptor Antagonists Sales Forecast by Application (2021-2026)
5.2.2 Global Alpha-Adrenoreceptor Antagonists Revenue Forecast by Application (2021-2026)
5.2.3 Global Alpha-Adrenoreceptor Antagonists Price Forecast by Application (2021-2026)

6 North America
6.1 North America Alpha-Adrenoreceptor Antagonists by Country
6.1.1 North America Alpha-Adrenoreceptor Antagonists Sales by Country
6.1.2 North America Alpha-Adrenoreceptor Antagonists Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Alpha-Adrenoreceptor Antagonists Market Facts & Figures by Type
6.3 North America Alpha-Adrenoreceptor Antagonists Market Facts & Figures by Application

7 Europe
7.1 Europe Alpha-Adrenoreceptor Antagonists by Country
7.1.1 Europe Alpha-Adrenoreceptor Antagonists Sales by Country
7.1.2 Europe Alpha-Adrenoreceptor Antagonists Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Alpha-Adrenoreceptor Antagonists Market Facts & Figures by Type
7.3 Europe Alpha-Adrenoreceptor Antagonists Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Alpha-Adrenoreceptor Antagonists by Region
8.1.1 Asia Pacific Alpha-Adrenoreceptor Antagonists Sales by Region
8.1.2 Asia Pacific Alpha-Adrenoreceptor Antagonists Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Alpha-Adrenoreceptor Antagonists Market Facts & Figures by Type
8.3 Asia Pacific Alpha-Adrenoreceptor Antagonists Market Facts & Figures by Application

9 Latin America
9.1 Latin America Alpha-Adrenoreceptor Antagonists by Country
9.1.1 Latin America Alpha-Adrenoreceptor Antagonists Sales by Country
9.1.2 Latin America Alpha-Adrenoreceptor Antagonists Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Alpha-Adrenoreceptor Antagonists Market Facts & Figures by Type
9.3 Central & South America Alpha-Adrenoreceptor Antagonists Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Alpha-Adrenoreceptor Antagonists by Country
10.1.1 Middle East and Africa Alpha-Adrenoreceptor Antagonists Sales by Country
10.1.2 Middle East and Africa Alpha-Adrenoreceptor Antagonists Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Alpha-Adrenoreceptor Antagonists Market Facts & Figures by Type
10.3 Middle East and Africa Alpha-Adrenoreceptor Antagonists Market Facts & Figures by Application

11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Description and Business Overview
11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi Alpha-Adrenoreceptor Antagonists Products Offered
11.1.5 Sanofi Related Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Description and Business Overview
11.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Pfizer Alpha-Adrenoreceptor Antagonists Products Offered
11.2.5 Pfizer Related Developments
11.3 Pro Doc
11.3.1 Pro Doc Corporation Information
11.3.2 Pro Doc Description and Business Overview
11.3.3 Pro Doc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Pro Doc Alpha-Adrenoreceptor Antagonists Products Offered
11.3.5 Pro Doc Related Developments
11.4 Concordia Pharmaceuticals
11.4.1 Concordia Pharmaceuticals Corporation Information
11.4.2 Concordia Pharmaceuticals Description and Business Overview
11.4.3 Concordia Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Concordia Pharmaceuticals Alpha-Adrenoreceptor Antagonists Products Offered
11.4.5 Concordia Pharmaceuticals Related Developments
11.5 Covis Pharmaceuticals
11.5.1 Covis Pharmaceuticals Corporation Information
11.5.2 Covis Pharmaceuticals Description and Business Overview
11.5.3 Covis Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Covis Pharmaceuticals Alpha-Adrenoreceptor Antagonists Products Offered
11.5.5 Covis Pharmaceuticals Related Developments
11.6 Aspri Pharma
11.6.1 Aspri Pharma Corporation Information
11.6.2 Aspri Pharma Description and Business Overview
11.6.3 Aspri Pharma Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Aspri Pharma Alpha-Adrenoreceptor Antagonists Products Offered
11.6.5 Aspri Pharma Related Developments
11.7 Roerig
11.7.1 Roerig Corporation Information
11.7.2 Roerig Description and Business Overview
11.7.3 Roerig Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Roerig Alpha-Adrenoreceptor Antagonists Products Offered
11.7.5 Roerig Related Developments
11.8 Greenstone
11.8.1 Greenstone Corporation Information
11.8.2 Greenstone Description and Business Overview
11.8.3 Greenstone Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Greenstone Alpha-Adrenoreceptor Antagonists Products Offered
11.8.5 Greenstone Related Developments
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Corporation Information
11.9.2 Boehringer Ingelheim Description and Business Overview
11.9.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Boehringer Ingelheim Alpha-Adrenoreceptor Antagonists Products Offered
11.9.5 Boehringer Ingelheim Related Developments
11.10 Cardinal Health
11.10.1 Cardinal Health Corporation Information
11.10.2 Cardinal Health Description and Business Overview
11.10.3 Cardinal Health Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Cardinal Health Alpha-Adrenoreceptor Antagonists Products Offered
11.10.5 Cardinal Health Related Developments
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Description and Business Overview
11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi Alpha-Adrenoreceptor Antagonists Products Offered
11.1.5 Sanofi Related Developments
11.12 Glaxosmithkline
11.12.1 Glaxosmithkline Corporation Information
11.12.2 Glaxosmithkline Description and Business Overview
11.12.3 Glaxosmithkline Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Glaxosmithkline Products Offered
11.12.5 Glaxosmithkline Related Developments
11.13 Actavis
11.13.1 Actavis Corporation Information
11.13.2 Actavis Description and Business Overview
11.13.3 Actavis Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Actavis Products Offered
11.13.5 Actavis Related Developments
11.14 Merck
11.14.1 Merck Corporation Information
11.14.2 Merck Description and Business Overview
11.14.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Merck Products Offered
11.14.5 Merck Related Developments
11.15 Jubilant Generics
11.15.1 Jubilant Generics Corporation Information
11.15.2 Jubilant Generics Description and Business Overview
11.15.3 Jubilant Generics Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Jubilant Generics Products Offered
11.15.5 Jubilant Generics Related Developments
11.16 Astellas Pharma
11.16.1 Astellas Pharma Corporation Information
11.16.2 Astellas Pharma Description and Business Overview
11.16.3 Astellas Pharma Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Astellas Pharma Products Offered
11.16.5 Astellas Pharma Related Developments
11.17 Allergan
11.17.1 Allergan Corporation Information
11.17.2 Allergan Description and Business Overview
11.17.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Allergan Products Offered
11.17.5 Allergan Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Alpha-Adrenoreceptor Antagonists Market Estimates and Projections by Region
12.1.1 Global Alpha-Adrenoreceptor Antagonists Sales Forecast by Regions 2021-2026
12.1.2 Global Alpha-Adrenoreceptor Antagonists Revenue Forecast by Regions 2021-2026
12.2 North America Alpha-Adrenoreceptor Antagonists Market Size Forecast (2021-2026)
12.2.1 North America: Alpha-Adrenoreceptor Antagonists Sales Forecast (2021-2026)
12.2.2 North America: Alpha-Adrenoreceptor Antagonists Revenue Forecast (2021-2026)
12.2.3 North America: Alpha-Adrenoreceptor Antagonists Market Size Forecast by Country (2021-2026)
12.3 Europe Alpha-Adrenoreceptor Antagonists Market Size Forecast (2021-2026)
12.3.1 Europe: Alpha-Adrenoreceptor Antagonists Sales Forecast (2021-2026)
12.3.2 Europe: Alpha-Adrenoreceptor Antagonists Revenue Forecast (2021-2026)
12.3.3 Europe: Alpha-Adrenoreceptor Antagonists Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Alpha-Adrenoreceptor Antagonists Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Alpha-Adrenoreceptor Antagonists Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Alpha-Adrenoreceptor Antagonists Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Alpha-Adrenoreceptor Antagonists Market Size Forecast by Region (2021-2026)
12.5 Latin America Alpha-Adrenoreceptor Antagonists Market Size Forecast (2021-2026)
12.5.1 Latin America: Alpha-Adrenoreceptor Antagonists Sales Forecast (2021-2026)
12.5.2 Latin America: Alpha-Adrenoreceptor Antagonists Revenue Forecast (2021-2026)
12.5.3 Latin America: Alpha-Adrenoreceptor Antagonists Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Alpha-Adrenoreceptor Antagonists Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Alpha-Adrenoreceptor Antagonists Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Alpha-Adrenoreceptor Antagonists Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Alpha-Adrenoreceptor Antagonists Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Alpha-Adrenoreceptor Antagonists Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Alpha-Adrenoreceptor Antagonists Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Alpha-Adrenoreceptor Antagonists Market Segments
Table 2. Ranking of Global Top Alpha-Adrenoreceptor Antagonists Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Alpha-Adrenoreceptor Antagonists Market Size Growth Rate by Type 2020-2026 (Kiloton) & (US$ Million)
Table 4. Major Manufacturers of Oral
Table 5. Major Manufacturers of Injection
Table 6. Global Alpha-Adrenoreceptor Antagonists Market Size Growth Rate by Application 2020-2026 (Kiloton)
Table 7. Global Alpha-Adrenoreceptor Antagonists Market Size by Region (Kiloton) & (US$ Million): 2020 VS 2026
Table 8. Global Alpha-Adrenoreceptor Antagonists Sales by Regions 2015-2020 (Kiloton)
Table 9. Global Alpha-Adrenoreceptor Antagonists Sales Market Share by Regions (2015-2020)
Table 10. Global Alpha-Adrenoreceptor Antagonists Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Alpha-Adrenoreceptor Antagonists Sales by Manufacturers (2015-2020) (Kiloton)
Table 12. Global Alpha-Adrenoreceptor Antagonists Sales Share by Manufacturers (2015-2020)
Table 13. Global Alpha-Adrenoreceptor Antagonists Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Alpha-Adrenoreceptor Antagonists by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alpha-Adrenoreceptor Antagonists as of 2019)
Table 15. Alpha-Adrenoreceptor Antagonists Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Alpha-Adrenoreceptor Antagonists Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Alpha-Adrenoreceptor Antagonists Price (2015-2020) (US$/Ton)
Table 18. Alpha-Adrenoreceptor Antagonists Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Alpha-Adrenoreceptor Antagonists Product Type
Table 20. Date of International Manufacturers Enter into Alpha-Adrenoreceptor Antagonists Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Alpha-Adrenoreceptor Antagonists Sales by Type (2015-2020) (Kiloton)
Table 23. Global Alpha-Adrenoreceptor Antagonists Sales Share by Type (2015-2020)
Table 24. Global Alpha-Adrenoreceptor Antagonists Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Alpha-Adrenoreceptor Antagonists Revenue Share by Type (2015-2020)
Table 26. Alpha-Adrenoreceptor Antagonists Average Selling Price (ASP) by Type 2015-2020 (US$/Ton)
Table 27. Global Alpha-Adrenoreceptor Antagonists Sales by Application (2015-2020) (Kiloton)
Table 28. Global Alpha-Adrenoreceptor Antagonists Sales Share by Application (2015-2020)
Table 29. North America Alpha-Adrenoreceptor Antagonists Sales by Country (2015-2020) (Kiloton)
Table 30. North America Alpha-Adrenoreceptor Antagonists Sales Market Share by Country (2015-2020)
Table 31. North America Alpha-Adrenoreceptor Antagonists Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Alpha-Adrenoreceptor Antagonists Revenue Market Share by Country (2015-2020)
Table 33. North America Alpha-Adrenoreceptor Antagonists Sales by Type (2015-2020) (Kiloton)
Table 34. North America Alpha-Adrenoreceptor Antagonists Sales Market Share by Type (2015-2020)
Table 35. North America Alpha-Adrenoreceptor Antagonists Sales by Application (2015-2020) (Kiloton)
Table 36. North America Alpha-Adrenoreceptor Antagonists Sales Market Share by Application (2015-2020)
Table 37. Europe Alpha-Adrenoreceptor Antagonists Sales by Country (2015-2020) (Kiloton)
Table 38. Europe Alpha-Adrenoreceptor Antagonists Sales Market Share by Country (2015-2020)
Table 39. Europe Alpha-Adrenoreceptor Antagonists Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Alpha-Adrenoreceptor Antagonists Revenue Market Share by Country (2015-2020)
Table 41. Europe Alpha-Adrenoreceptor Antagonists Sales by Type (2015-2020) (Kiloton)
Table 42. Europe Alpha-Adrenoreceptor Antagonists Sales Market Share by Type (2015-2020)
Table 43. Europe Alpha-Adrenoreceptor Antagonists Sales by Application (2015-2020) (Kiloton)
Table 44. Europe Alpha-Adrenoreceptor Antagonists Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Alpha-Adrenoreceptor Antagonists Sales by Region (2015-2020) (Kiloton)
Table 46. Asia Pacific Alpha-Adrenoreceptor Antagonists Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Alpha-Adrenoreceptor Antagonists Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Alpha-Adrenoreceptor Antagonists Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Alpha-Adrenoreceptor Antagonists Sales by Type (2015-2020) (Kiloton)
Table 50. Asia Pacific Alpha-Adrenoreceptor Antagonists Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Alpha-Adrenoreceptor Antagonists Sales by Application (2015-2020) (Kiloton)
Table 52. Asia Pacific Alpha-Adrenoreceptor Antagonists Sales Market Share by Application (2015-2020)
Table 53. Latin America Alpha-Adrenoreceptor Antagonists Sales by Country (2015-2020) (Kiloton)
Table 54. Latin America Alpha-Adrenoreceptor Antagonists Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Alpha-Adrenoreceptor Antagonists Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Alpha-Adrenoreceptor Antagonists Revenue Market Share by Country (2015-2020)
Table 57. Latin America Alpha-Adrenoreceptor Antagonists Sales by Type (2015-2020) (Kiloton)
Table 58. Latin America Alpha-Adrenoreceptor Antagonists Sales Market Share by Type (2015-2020)
Table 59. Latin America Alpha-Adrenoreceptor Antagonists Sales by Application (2015-2020) (Kiloton)
Table 60. Latin America Alpha-Adrenoreceptor Antagonists Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Alpha-Adrenoreceptor Antagonists Sales by Country (2015-2020) (Kiloton)
Table 62. Middle East and Africa Alpha-Adrenoreceptor Antagonists Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Alpha-Adrenoreceptor Antagonists Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Alpha-Adrenoreceptor Antagonists Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Alpha-Adrenoreceptor Antagonists Sales by Type (2015-2020) (Kiloton)
Table 66. Middle East and Africa Alpha-Adrenoreceptor Antagonists Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Alpha-Adrenoreceptor Antagonists Sales by Application (2015-2020) (Kiloton)
Table 68. Middle East and Africa Alpha-Adrenoreceptor Antagonists Sales Market Share by Application (2015-2020)
Table 69. Sanofi Corporation Information
Table 70. Sanofi Description and Major Businesses
Table 71. Sanofi Alpha-Adrenoreceptor Antagonists Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 72. Sanofi Product
Table 73. Sanofi Recent Development
Table 74. Pfizer Corporation Information
Table 75. Pfizer Description and Major Businesses
Table 76. Pfizer Alpha-Adrenoreceptor Antagonists Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 77. Pfizer Product
Table 78. Pfizer Recent Development
Table 79. Pro Doc Corporation Information
Table 80. Pro Doc Description and Major Businesses
Table 81. Pro Doc Alpha-Adrenoreceptor Antagonists Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 82. Pro Doc Product
Table 83. Pro Doc Recent Development
Table 84. Concordia Pharmaceuticals Corporation Information
Table 85. Concordia Pharmaceuticals Description and Major Businesses
Table 86. Concordia Pharmaceuticals Alpha-Adrenoreceptor Antagonists Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 87. Concordia Pharmaceuticals Product
Table 88. Concordia Pharmaceuticals Recent Development
Table 89. Covis Pharmaceuticals Corporation Information
Table 90. Covis Pharmaceuticals Description and Major Businesses
Table 91. Covis Pharmaceuticals Alpha-Adrenoreceptor Antagonists Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 92. Covis Pharmaceuticals Product
Table 93. Covis Pharmaceuticals Recent Development
Table 94. Aspri Pharma Corporation Information
Table 95. Aspri Pharma Description and Major Businesses
Table 96. Aspri Pharma Alpha-Adrenoreceptor Antagonists Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 97. Aspri Pharma Product
Table 98. Aspri Pharma Recent Development
Table 99. Roerig Corporation Information
Table 100. Roerig Description and Major Businesses
Table 101. Roerig Alpha-Adrenoreceptor Antagonists Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 102. Roerig Product
Table 103. Roerig Recent Development
Table 104. Greenstone Corporation Information
Table 105. Greenstone Description and Major Businesses
Table 106. Greenstone Alpha-Adrenoreceptor Antagonists Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 107. Greenstone Product
Table 108. Greenstone Recent Development
Table 109. Boehringer Ingelheim Corporation Information
Table 110. Boehringer Ingelheim Description and Major Businesses
Table 111. Boehringer Ingelheim Alpha-Adrenoreceptor Antagonists Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 112. Boehringer Ingelheim Product
Table 113. Boehringer Ingelheim Recent Development
Table 114. Cardinal Health Corporation Information
Table 115. Cardinal Health Description and Major Businesses
Table 116. Cardinal Health Alpha-Adrenoreceptor Antagonists Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 117. Cardinal Health Product
Table 118. Cardinal Health Recent Development
Table 119. Teva Corporation Information
Table 120. Teva Description and Major Businesses
Table 121. Teva Alpha-Adrenoreceptor Antagonists Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 122. Teva Product
Table 123. Teva Recent Development
Table 124. Glaxosmithkline Corporation Information
Table 125. Glaxosmithkline Description and Major Businesses
Table 126. Glaxosmithkline Alpha-Adrenoreceptor Antagonists Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 127. Glaxosmithkline Product
Table 128. Glaxosmithkline Recent Development
Table 129. Actavis Corporation Information
Table 130. Actavis Description and Major Businesses
Table 131. Actavis Alpha-Adrenoreceptor Antagonists Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 132. Actavis Product
Table 133. Actavis Recent Development
Table 134. Merck Corporation Information
Table 135. Merck Description and Major Businesses
Table 136. Merck Alpha-Adrenoreceptor Antagonists Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 137. Merck Product
Table 138. Merck Recent Development
Table 139. Jubilant Generics Corporation Information
Table 140. Jubilant Generics Description and Major Businesses
Table 141. Jubilant Generics Alpha-Adrenoreceptor Antagonists Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 142. Jubilant Generics Product
Table 143. Jubilant Generics Recent Development
Table 144. Astellas Pharma Corporation Information
Table 145. Astellas Pharma Description and Major Businesses
Table 146. Astellas Pharma Alpha-Adrenoreceptor Antagonists Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 147. Astellas Pharma Product
Table 148. Astellas Pharma Recent Development
Table 149. Allergan Corporation Information
Table 150. Allergan Description and Major Businesses
Table 151. Allergan Alpha-Adrenoreceptor Antagonists Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 152. Allergan Product
Table 153. Allergan Recent Development
Table 154. Global Alpha-Adrenoreceptor Antagonists Sales Forecast by Regions (2021-2026) (Kiloton)
Table 155. Global Alpha-Adrenoreceptor Antagonists Sales Market Share Forecast by Regions (2021-2026)
Table 156. Global Alpha-Adrenoreceptor Antagonists Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 157. Global Alpha-Adrenoreceptor Antagonists Revenue Market Share Forecast by Regions (2021-2026)
Table 158. North America: Alpha-Adrenoreceptor Antagonists Sales Forecast by Country (2021-2026) (Kiloton)
Table 159. North America: Alpha-Adrenoreceptor Antagonists Revenue Forecast by Country (2021-2026) (US$ Million)
Table 160. Europe: Alpha-Adrenoreceptor Antagonists Sales Forecast by Country (2021-2026) (Kiloton)
Table 161. Europe: Alpha-Adrenoreceptor Antagonists Revenue Forecast by Country (2021-2026) (US$ Million)
Table 162. Asia Pacific: Alpha-Adrenoreceptor Antagonists Sales Forecast by Region (2021-2026) (Kiloton)
Table 163. Asia Pacific: Alpha-Adrenoreceptor Antagonists Revenue Forecast by Region (2021-2026) (US$ Million)
Table 164. Latin America: Alpha-Adrenoreceptor Antagonists Sales Forecast by Country (2021-2026) (Kiloton)
Table 165. Latin America: Alpha-Adrenoreceptor Antagonists Revenue Forecast by Country (2021-2026) (US$ Million)
Table 166. Middle East and Africa: Alpha-Adrenoreceptor Antagonists Sales Forecast by Country (2021-2026) (Kiloton)
Table 167. Middle East and Africa: Alpha-Adrenoreceptor Antagonists Revenue Forecast by Country (2021-2026) (US$ Million)
Table 168. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 169. Key Challenges
Table 170. Market Risks
Table 171. Main Points Interviewed from Key Alpha-Adrenoreceptor Antagonists Players
Table 172. Alpha-Adrenoreceptor Antagonists Customers List
Table 173. Alpha-Adrenoreceptor Antagonists Distributors List
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources
List of Figures
Figure 1. Alpha-Adrenoreceptor Antagonists Product Picture
Figure 2. Global Alpha-Adrenoreceptor Antagonists Sales Market Share by Type in 2020 & 2026
Figure 3. Oral Product Picture
Figure 4. Injection Product Picture
Figure 5. Global Alpha-Adrenoreceptor Antagonists Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Alpha-Adrenoreceptor Antagonists Report Years Considered
Figure 9. Global Alpha-Adrenoreceptor Antagonists Market Size 2015-2026 (US$ Million)
Figure 10. Global Alpha-Adrenoreceptor Antagonists Sales 2015-2026 (Kiloton)
Figure 11. Global Alpha-Adrenoreceptor Antagonists Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Alpha-Adrenoreceptor Antagonists Sales Market Share by Region (2015-2020)
Figure 13. Global Alpha-Adrenoreceptor Antagonists Sales Market Share by Region in 2019
Figure 14. Global Alpha-Adrenoreceptor Antagonists Revenue Market Share by Region (2015-2020)
Figure 15. Global Alpha-Adrenoreceptor Antagonists Revenue Market Share by Region in 2019
Figure 16. Global Alpha-Adrenoreceptor Antagonists Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Alpha-Adrenoreceptor Antagonists Revenue in 2019
Figure 18. Alpha-Adrenoreceptor Antagonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Alpha-Adrenoreceptor Antagonists Sales Market Share by Type (2015-2020)
Figure 20. Global Alpha-Adrenoreceptor Antagonists Sales Market Share by Type in 2019
Figure 21. Global Alpha-Adrenoreceptor Antagonists Revenue Market Share by Type (2015-2020)
Figure 22. Global Alpha-Adrenoreceptor Antagonists Revenue Market Share by Type in 2019
Figure 23. Global Alpha-Adrenoreceptor Antagonists Market Share by Price Range (2015-2020)
Figure 24. Global Alpha-Adrenoreceptor Antagonists Sales Market Share by Application (2015-2020)
Figure 25. Global Alpha-Adrenoreceptor Antagonists Sales Market Share by Application in 2019
Figure 26. Global Alpha-Adrenoreceptor Antagonists Revenue Market Share by Application (2015-2020)
Figure 27. Global Alpha-Adrenoreceptor Antagonists Revenue Market Share by Application in 2019
Figure 28. North America Alpha-Adrenoreceptor Antagonists Sales Growth Rate 2015-2020 (Kiloton)
Figure 29. North America Alpha-Adrenoreceptor Antagonists Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Alpha-Adrenoreceptor Antagonists Sales Market Share by Country in 2019
Figure 31. North America Alpha-Adrenoreceptor Antagonists Revenue Market Share by Country in 2019
Figure 32. U.S. Alpha-Adrenoreceptor Antagonists Sales Growth Rate (2015-2020) (Kiloton)
Figure 33. U.S. Alpha-Adrenoreceptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Alpha-Adrenoreceptor Antagonists Sales Growth Rate (2015-2020) (Kiloton)
Figure 35. Canada Alpha-Adrenoreceptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Alpha-Adrenoreceptor Antagonists Market Share by Type in 2019
Figure 37. North America Alpha-Adrenoreceptor Antagonists Market Share by Application in 2019
Figure 38. Europe Alpha-Adrenoreceptor Antagonists Sales Growth Rate 2015-2020 (Kiloton)
Figure 39. Europe Alpha-Adrenoreceptor Antagonists Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Alpha-Adrenoreceptor Antagonists Sales Market Share by Country in 2019
Figure 41. Europe Alpha-Adrenoreceptor Antagonists Revenue Market Share by Country in 2019
Figure 42. Germany Alpha-Adrenoreceptor Antagonists Sales Growth Rate (2015-2020) (Kiloton)
Figure 43. Germany Alpha-Adrenoreceptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Alpha-Adrenoreceptor Antagonists Sales Growth Rate (2015-2020) (Kiloton)
Figure 45. France Alpha-Adrenoreceptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Alpha-Adrenoreceptor Antagonists Sales Growth Rate (2015-2020) (Kiloton)
Figure 47. U.K. Alpha-Adrenoreceptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Alpha-Adrenoreceptor Antagonists Sales Growth Rate (2015-2020) (Kiloton)
Figure 49. Italy Alpha-Adrenoreceptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Alpha-Adrenoreceptor Antagonists Sales Growth Rate (2015-2020) (Kiloton)
Figure 51. Russia Alpha-Adrenoreceptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Alpha-Adrenoreceptor Antagonists Market Share by Type in 2019
Figure 53. Europe Alpha-Adrenoreceptor Antagonists Market Share by Application in 2019
Figure 54. Asia Pacific Alpha-Adrenoreceptor Antagonists Sales Growth Rate 2015-2020 (Kiloton)
Figure 55. Asia Pacific Alpha-Adrenoreceptor Antagonists Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Alpha-Adrenoreceptor Antagonists Sales Market Share by Region in 2019
Figure 57. Asia Pacific Alpha-Adrenoreceptor Antagonists Revenue Market Share by Region in 2019
Figure 58. China Alpha-Adrenoreceptor Antagonists Sales Growth Rate (2015-2020) (Kiloton)
Figure 59. China Alpha-Adrenoreceptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Alpha-Adrenoreceptor Antagonists Sales Growth Rate (2015-2020) (Kiloton)
Figure 61. Japan Alpha-Adrenoreceptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Alpha-Adrenoreceptor Antagonists Sales Growth Rate (2015-2020) (Kiloton)
Figure 63. South Korea Alpha-Adrenoreceptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Alpha-Adrenoreceptor Antagonists Sales Growth Rate (2015-2020) (Kiloton)
Figure 65. India Alpha-Adrenoreceptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Alpha-Adrenoreceptor Antagonists Sales Growth Rate (2015-2020) (Kiloton)
Figure 67. Australia Alpha-Adrenoreceptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Alpha-Adrenoreceptor Antagonists Sales Growth Rate (2015-2020) (Kiloton)
Figure 69. Taiwan Alpha-Adrenoreceptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Alpha-Adrenoreceptor Antagonists Sales Growth Rate (2015-2020) (Kiloton)
Figure 71. Indonesia Alpha-Adrenoreceptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Alpha-Adrenoreceptor Antagonists Sales Growth Rate (2015-2020) (Kiloton)
Figure 73. Thailand Alpha-Adrenoreceptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Alpha-Adrenoreceptor Antagonists Sales Growth Rate (2015-2020) (Kiloton)
Figure 75. Malaysia Alpha-Adrenoreceptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Alpha-Adrenoreceptor Antagonists Sales Growth Rate (2015-2020) (Kiloton)
Figure 77. Philippines Alpha-Adrenoreceptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Alpha-Adrenoreceptor Antagonists Sales Growth Rate (2015-2020) (Kiloton)
Figure 79. Vietnam Alpha-Adrenoreceptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Alpha-Adrenoreceptor Antagonists Market Share by Type in 2019
Figure 81. Asia Pacific Alpha-Adrenoreceptor Antagonists Market Share by Application in 2019
Figure 82. Latin America Alpha-Adrenoreceptor Antagonists Sales Growth Rate 2015-2020 (Kiloton)
Figure 83. Latin America Alpha-Adrenoreceptor Antagonists Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Alpha-Adrenoreceptor Antagonists Sales Market Share by Country in 2019
Figure 85. Latin America Alpha-Adrenoreceptor Antagonists Revenue Market Share by Country in 2019
Figure 86. Mexico Alpha-Adrenoreceptor Antagonists Sales Growth Rate (2015-2020) (Kiloton)
Figure 87. Mexico Alpha-Adrenoreceptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Alpha-Adrenoreceptor Antagonists Sales Growth Rate (2015-2020) (Kiloton)
Figure 89. Brazil Alpha-Adrenoreceptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Alpha-Adrenoreceptor Antagonists Sales Growth Rate (2015-2020) (Kiloton)
Figure 91. Argentina Alpha-Adrenoreceptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Alpha-Adrenoreceptor Antagonists Market Share by Type in 2019
Figure 93. Latin America Alpha-Adrenoreceptor Antagonists Market Share by Application in 2019
Figure 94. Middle East and Africa Alpha-Adrenoreceptor Antagonists Sales Growth Rate 2015-2020 (Kiloton)
Figure 95. Middle East and Africa Alpha-Adrenoreceptor Antagonists Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Alpha-Adrenoreceptor Antagonists Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Alpha-Adrenoreceptor Antagonists Revenue Market Share by Country in 2019
Figure 98. Turkey Alpha-Adrenoreceptor Antagonists Sales Growth Rate (2015-2020) (Kiloton)
Figure 99. Turkey Alpha-Adrenoreceptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Alpha-Adrenoreceptor Antagonists Sales Growth Rate (2015-2020) (Kiloton)
Figure 101. Saudi Arabia Alpha-Adrenoreceptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. UAE Alpha-Adrenoreceptor Antagonists Sales Growth Rate (2015-2020) (Kiloton)
Figure 103. UAE Alpha-Adrenoreceptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Alpha-Adrenoreceptor Antagonists Market Share by Type in 2019
Figure 105. Middle East and Africa Alpha-Adrenoreceptor Antagonists Market Share by Application in 2019
Figure 106. North America Alpha-Adrenoreceptor Antagonists Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 107. North America Alpha-Adrenoreceptor Antagonists Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 108. Europe Alpha-Adrenoreceptor Antagonists Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 109. Europe Alpha-Adrenoreceptor Antagonists Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Asia Pacific Alpha-Adrenoreceptor Antagonists Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 111. Asia Pacific Alpha-Adrenoreceptor Antagonists Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Latin America Alpha-Adrenoreceptor Antagonists Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 113. Latin America Alpha-Adrenoreceptor Antagonists Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Middle East and Africa Alpha-Adrenoreceptor Antagonists Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 115. Middle East and Africa Alpha-Adrenoreceptor Antagonists Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Porter's Five Forces Analysis
Figure 117. Channels of Distribution
Figure 118. Distributors Profiles
Figure 119. Bottom-up and Top-down Approaches for This Report
Figure 120. Data Triangulation
Figure 121. Key Executives Interviewed


【掲載企業】

Sanofi、Pfizer、Pro Doc、Concordia Pharmaceuticals、Covis Pharmaceuticals、Aspri Pharma、Roerig、Greenstone、Boehringer Ingelheim、Cardinal Health、Teva、Glaxosmithkline、Actavis、Merck、Jubilant Generics、Astellas Pharma、Allergan

★調査レポート[世界のα-アドレナリン受容体拮抗薬市場インサイト及び予測(~2026年)] (コード:QYR20NV02293)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のα-アドレナリン受容体拮抗薬市場インサイト及び予測(~2026年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆